Gary Moroff
Papers
1
Total Citations
15
H-Index
1
About
Gary Moroff has made foundational contributions to transfusion medicine, particularly in the mitigation of transfusion-related acute lung injury (TRALI), a leading cause of transfusion-associated morbidity. His key research areas include plateletpheresis donor safety, HLA antibody screening, and the optimization of blood component quality. Moroff’s most cited work, a 2010 study comparing two robotic platforms for screening plateletpheresis donors for HLA antibodies, directly addressed the critical need for high-throughput, reliable methods to identify at-risk donors as part of a TRALI mitigation strategy. This study, with 15 citations, provided essential comparative data that informed blood center practices and regulatory guidelines. Beyond this, Moroff has been instrumental in advancing donor screening protocols and understanding the immunological factors underlying adverse transfusion reactions. His research bridges laboratory innovation and clinical application, helping to make blood transfusions safer for millions of patients. Through his systematic approach to donor risk assessment, Moroff has left a lasting impact on transfusion safety standards, earning recognition as a key figure in the field.
Research Focus
Key Achievements
Top Papers
- 1